Skip to main content
. 2011 Mar 15;2011:716871. doi: 10.4061/2011/716871

Table 1.

Summary of mutations and links to mitochondrial dysfunction and PD.

Mutation Link to mitochondria Links with PD
α-synuclein Targeted to IMM and causes CI inhibition (i) Major component of LBs
(ii) Mutation linked with PD
Parkin Suggested role in mitochondrial function and antioxidant protection Mutation linked to autosomal recessive juvenile PD
PINK1 Interaction with Parkin Loss of kinase mutation linked to familial PD
DJ-1 (i) Antioxidant present in mitochondria
(ii) Rescues mitochondria from PINK1 deletion
Mutation linked with numerous cases of familial PD
Omi/Hrta2 (i) Mitochondrial location
(ii) Interaction with PINK1
Loss of function mutations found in PD patients
LRRK2 (i) Protects against mitochondrial CI toxin rotenone
(ii) Increases Parkin mediated cell protection
(iii) Located in outer mitochondrial membrane
Mutation linked with autosomal dominant PD
ATP13A2 Leads to lysosomal dysfunction and build up of α-synuclein which is toxic to CI Mutation linked with hereditary form of PD
PLA2G6 (i) Located in mitochondria
(ii) Protect mitochondria against oxidative stress
Mutations linked to neurodegeneration and recently PD
TFAM (i) Regulates transcription of mtDNA
(ii) Knockout mouse has respiratory chain deficiency
(i) Knockout mouse develops PD phenotype
(ii) Mutations in some variants give increased risk of PD
POLG1 (i) Involved in the synthesis and regulation of mtDNA
(ii) Linked to respiratory chain deficiency in PD
Mutation linked with PD